Novel Use of Restasis (Cyclosporine Ophthalmic Emulsion 0.05%) on Application of PROSE Devices for Management of Patients With Ocular Surface Disease: A Pilot Study
Latest Information Update: 21 Apr 2023
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes; Eye disorders
- Focus Therapeutic Use
- 18 Apr 2023 Status changed from recruiting to completed.
- 06 Mar 2022 Planned End Date changed from 15 Jan 2022 to 15 Dec 2022.
- 06 Mar 2022 Planned primary completion date changed from 15 Dec 2021 to 15 Dec 2022.